Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape |
Mar 2024 |
Blood Reviews |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Current and emerging strategies for management of myelodysplastic syndromes |
Dec 2020 |
Blood reviews |
Myelodysplastic Syndromes (MDS) |
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes |
Apr 2019 |
Blood Reviews |
Myelodysplastic Syndromes (MDS) |
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review |
Jul 2023 |
Blood Reviews |
Myelodysplastic Syndromes (MDS) |
Severe breakthrough hemolysis during compassionate use of Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: managing an emergency |
Jul 2024 |
Blood Transfusion |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria |
Dec 2020 |
Blood, cells, molecules & diseases |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge |
Apr 2019 |
BMJ Case Reports |
Myelodysplastic Syndromes (MDS) |
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study |
Apr 2021 |
BMJ Supportive & Palliative Care |
Myelodysplastic Syndromes (MDS) |
Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia |
Jan 2019 |
Bone Marrow Transplant |
Aplastic Anemia |
Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes. |
Jan 2019 |
Bone Marrow Transplant |
Myelodysplastic Syndromes (MDS) |